Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Insider

WVE

Wave Life Sciences Ltd.

May 17 • 04:00PM ET

6.26

Dollar change +0.36
Percentage change 6.10	%

Healthcare • Biotechnology • Singapore • NASD

Chart Stock Detail • Compare Perf. • Revenue • Dividends • Options Options Chain • Save to Portfolio • Create Alert

Held by: IWM VXF IWN IBB VTWO IWC ITOT ONEQ VTWV FHLC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.53	Insider Own	21.20%	Shs Outstand	119.16M	Perf Week	11.39%
Market Cap	766.60M	Forward P/E	-	EPS next Y	-0.91	Insider Trans	19.76%	Shs Float	96.50M	Perf Month	30.42%
Income	-61.92M	PEG	-	EPS next Q	-0.21	Inst Own	74.70%	Short Float	2.88%	Perf Quarter	60.10%
Sales	112.91M	P/S	6.79	EPS this Y	-68.83%	Inst Trans	-0.41%	Short Ratio	3.11	Perf Half Y	15.29%
Book/sh	0.21	P/B	30.16	EPS next Y	-0.18%	ROA	-24.64%	Short Interest	2.78M	Perf Year	70.57%
Cash/sh	1.48	P/C	4.24	EPS next 5Y	-	ROE	-1928.16%	52W Range	3.15 - 7.67	Perf YTD	23.96%
Dividend Est.	-	P/FCF	-	EPS past 5Y	36.03%	ROI	-108.90%	52W High	-18.38%	Beta	-1.05
Dividend TTM	-	Quick Ratio	1.19	Sales past 5Y	610.91%	Gross Margin	92.08%	52W Low	98.72%	ATR (14)	0.40
Dividend Ex-Date	-	Current Ratio	1.19	EPS Y/Y TTM	70.26%	Oper. Margin	-63.91%	RSI (14)	63.58	Volatility	5.57% 6.91%
Employees	268	Debt/Eq	0.92	Sales Y/Y TTM	661.49%	Profit Margin	-54.84%	Recom	1.43	Target Price	12.86
Option/Short	Yes / Yes	LT Debt/Eq	0.71	EPS Q/Q	9.09%	Payout	-	Rel Volume	1.23	Prev Close	5.90
Sales Surprise	-49.85%	EPS Surprise	-29.03%	Sales Q/Q	-3.02%	Earnings	May 09 BMO	Avg Volume	893.18K	Price	6.26
SMA20	15.11%	SMA50	8.27%	SMA200	21.18%	Trades		Volume	1,102,587	Change	6.10%

Date	Action	Analyst	Rating Change	Price Target Change
May-15-24	Initiated	Wells Fargo	Overweight	$11
Dec-19-23	Upgrade	Leerink Partners	Market Perform → Outperform	$5 → $12
Jul-05-23	Initiated	Raymond James	Outperform	$7
May-24-23	Downgrade	Jefferies	Buy → Hold	$7 → $5
Dec-15-20	Resumed	H.C. Wainwright	Buy	$20
Oct-23-20	Initiated	RBC Capital Mkts	Sector Perform	$13
Dec-31-19	Downgrade	SVB Leerink	Outperform → Mkt Perform	$33 → $10
Nov-01-19	Initiated	Guggenheim	Buy	$43
Jul-15-19	Initiated	Cowen	Market Perform
Apr-17-19	Reiterated	H.C. Wainwright	Buy	$49 → $33
Aug-07-18	Initiated	Stifel	Buy	$56
Jul-23-18	Initiated	H.C. Wainwright	Buy	$49
Mar-19-18	Reiterated	Mizuho	Buy	$34 → $65
Feb-15-17	Initiated	H.C. Wainwright	Buy	$41
Nov-10-16	Resumed	Leerink Partners	Outperform
Dec-07-15	Initiated	Sun Trust Rbsn Humphrey	Buy	$26
Dec-07-15	Initiated	Leerink Partners	Outperform	$20
Dec-07-15	Initiated	JMP Securities	Mkt Outperform	$52
Dec-07-15	Initiated	Jefferies	Buy	$28

Show Previous Ratings

May-15-24 07:16AM	Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target (MT Newswires)
May-10-24 04:53PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:39PM	WAVE Life Sciences Reports First Quarter 2024 Financial Results (GuruFocus.com)
May-09-24 07:45AM	Wave Life Sciences: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
07:00AM	Loading…
07:00AM	Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer (GlobeNewswire)
May-07-24 08:30AM	Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
May-02-24 08:30AM	Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024 (GlobeNewswire)
Apr-30-24 08:30AM	Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD) (GlobeNewswire)
Apr-23-24 08:30AM	Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing (GlobeNewswire)
Mar-27-24 08:30AM	Wave Life Sciences to Present at Upcoming Investor Conferences (GlobeNewswire) +6.71%
Mar-15-24 08:18AM	Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks (Insider Monkey)
Mar-07-24 10:47AM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2023 Earnings Call Transcript (Insider Monkey) +8.43%
Mar-06-24 12:51PM	WVE Stock Earnings: WAVE Life Sciences Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace) +31.32%
07:51AM	Wave Life Sciences: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Loading…
07:30AM	Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Feb-28-24 08:30AM	Wave Life Sciences Fourth Quarter and Full Year 2023 Financial Results Scheduled for March 6, 2024 (GlobeNewswire)
04:16AM	Wave Life Sciences (WVE) Surges 10.9%: Is This an Indication of Further Gains? (Zacks)
Feb-27-24 08:30AM	Wave Life Sciences Announces Upcoming Presentations at MDA Conference that Highlight Best-in-Class Potential for WVE-N531 in Duchenne Muscular Dystrophy (GlobeNewswire) +10.87%
Feb-06-24 01:17PM	Hedge Fund and Insider Trading News: John Paulson, Dan Loeb, Millennium Management, Wave Life Sciences Ltd. (WVE), Super Micro Computer Inc (SMCI), and More (Insider Monkey)
Jan-31-24 01:21PM	Hedge Fund and Insider Trading News: Ken Griffin, Seth Klarman, Millennium Management, Wave Life Sciences Ltd. (WVE), Columbia Banking System Inc (COLB), and More (Insider Monkey)
Jan-08-24 08:00AM	Wave Life Sciences Highlights Recent Achievements and Upcoming 2024 Milestones (GlobeNewswire) +5.06%
Jan-03-24 08:30AM	Wave Life Sciences to Present at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-15-23 08:30AM	Wave Life Sciences Announces Initiation of Dosing in Phase 2 FORWARD-53 Trial of WVE-N531 in Duchenne Muscular Dystrophy (GlobeNewswire)
Dec-07-23 07:00AM	Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares (GlobeNewswire) -30.42%
Dec-06-23 04:10PM	Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants (GlobeNewswire) +9.22%
04:08PM	Wave Life Sciences Announces Initiation of Dosing in RestorAATion Clinical Program Evaluating First-Ever RNA Editing Candidate, WVE-006, for Alpha-1 Antitrypsin Deficiency (GlobeNewswire)
Nov-22-23 08:30AM	Wave Life Sciences to Present at 6 Annual Evercore ISI HealthCONx Conference (GlobeNewswire)
Nov-11-23 12:09PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 08:38AM	WAVE Life Sciences Ltd (WVE) Reports Notable Shift to Profitability in Q3 2023 (GuruFocus.com) -9.55%
07:43AM	Loading…
07:43AM	Wave Life Sciences: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Wave Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-03-23 04:05PM	Wave Life Sciences Third Quarter 2023 Financial Results Scheduled for November 9, 2023 (GlobeNewswire) +6.02%
Sep-29-23 05:47AM	Wave Life Sciences (WVE) Soars 8.7%: Is Further Upside Left in the Stock? (Zacks)
Sep-28-23 04:15PM	Wave Life Sciences Highlights Growth Strategy for Building the Leading RNA Medicines Company in Annual R&D Day (GlobeNewswire) +8.71%
Sep-25-23 08:30AM	Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-06-23 08:30AM	Wave Life Sciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Sep-05-23 07:30AM	Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-006, the First-ever RNA Editing Clinical Candidate, and Plans for Upcoming Virtual R&D Day (GlobeNewswire)
Aug-23-23 11:13AM	WAVE Life Sciences Ltd. Sees a 23% Stock Price Surge Over the Past Three Months (GuruFocus.com) +6.99%
Aug-17-23 08:44AM	11 Best Biotech Penny Stocks to Buy Now (Insider Monkey)
06:40AM	7 A-Rated Biotech Stocks for Your August Buy List (InvestorPlace)
Aug-10-23 12:40PM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-08-23 06:02AM	Analyst Forecasts For Wave Life Sciences Ltd. (NASDAQ:WVE) Are Surging Higher (Simply Wall St.)
Aug-04-23 06:45AM	Wave Life Sciences Ltd.'s (NASDAQ:WVE) 42% Price Boost Is Out Of Tune With Revenues (Simply Wall St.)
Aug-03-23 08:55AM	Wave Life Sciences (WVE) Reports Q2 Loss, Tops Revenue Estimates (Zacks) +15.79%
07:53AM	Wave Life Sciences: Q2 Earnings Snapshot (AP Finance)
07:30AM	Wave Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Jul-27-23 08:30AM	Wave Life Sciences Second Quarter 2023 Financial Results Scheduled for August 3, 2023 (GlobeNewswire)
Jul-06-23 08:40AM	Wave Life Sciences (NASDAQ:WVE) shareholders have endured a 90% loss from investing in the stock five years ago (Simply Wall St.)
Jun-26-23 08:30AM	Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes (GlobeNewswire)
Jun-19-23 08:00AM	Top Penny Stocks for Q3 2023 (Investopedia)
May-23-23 07:30AM	Wave Life Sciences Announces Topline Results from Phase 1b/2a FOCUS-C9 Study of WVE-004 for C9orf72-associated Amyotrophic Lateral Sclerosis and Frontotemporal Dementia (GlobeNewswire)
May-16-23 08:30AM	Wave Life Sciences to Highlight Leading RNA Editing Capability and Multimodal Discovery and Development Platform at ASGCT 26th Annual Meeting (GlobeNewswire) -7.94%
May-08-23 06:03AM	The Consensus EPS Estimates For Wave Life Sciences Ltd. (NASDAQ:WVE) Just Fell Dramatically (Simply Wall St.)
May-05-23 06:19AM	Wave Life Sciences First Quarter 2023 Earnings: Misses Expectations (Simply Wall St.) +9.32%
May-03-23 08:55AM	Wave Life Sciences (WVE) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:49AM	Wave Life Sciences: Q1 Earnings Snapshot (AP Finance)
07:30AM	Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Apr-26-23 08:30AM	Wave Life Sciences First Quarter 2023 Financial Results Scheduled for May 3, 2023 (GlobeNewswire)
Apr-20-23 08:30AM	Wave Life Sciences Announces Nucleic Acids Research Publication Highlighting Potential Best-in-Class siRNAs Designed with Wave Platform Chemistry (GlobeNewswire)
Mar-29-23 08:54AM	Can Wave Life Sciences (NASDAQ:WVE) Afford To Invest In Growth? (Simply Wall St.) +8.48%
08:00AM	Wave Life Sciences to Present at the Guggenheim Genomic Medicines and Rare Disease Days (GlobeNewswire)
Mar-24-23 07:36AM	Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.04%
Mar-22-23 08:45AM	Wave Life Sciences (WVE) Reports Q4 Loss, Misses Revenue Estimates (Zacks) -10.38%
07:30AM	Wave Life Sciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Mar-02-23 08:30AM	Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023 (GlobeNewswire)
Feb-14-23 12:00PM	Wave Life Sciences (WVE) Upgraded to Buy: Here's What You Should Know (Zacks)
09:35AM	After Plunging -23.26% in 4 Weeks, Here's Why the Trend Might Reverse for Wave Life Sciences (WVE) (Zacks)
Feb-09-23 04:05PM	Wave Life Sciences to Present at the 2023 Virtual SVB Securities Global Biopharma Conference (GlobeNewswire)
Jan-25-23 06:06AM	Wave Life Sciences (NASDAQ:WVE) shareholders have earned a 115% return over the last year (Simply Wall St.)
Jan-13-23 07:26AM	Morphic Holding, Inc. (MORF) Surges 18.7%: Is This an Indication of Further Gains? (Zacks)
Jan-03-23 05:40AM	The Zacks Analyst Blog Highlights AVEO Pharmaceuticals, Cabaletta Bio, Verona Pharma and Wave Life Sciences (Zacks) -11.43%
Dec-30-22 12:00PM	All You Need to Know About Wave Life Sciences (WVE) Rating Upgrade to Buy (Zacks)
09:03AM	4 Drug Stocks That More Than Doubled This Year (Zacks)
Dec-19-22 01:04PM	Wave Life Sciences Touts Encouraging Data From Duchenne Muscular Dystrophy Study (Benzinga)
07:37AM	Wave Life Sciences Provides Positive Update on Proof-of-Concept Study for WVE-N531 in Duchenne Muscular Dystrophy (GlobeNewswire)
Dec-15-22 09:07AM	Wave Life Sciences (WVE) Up 26% on Collaboration With GSK (Zacks) -10.47%
06:11AM	Wave Life Sciences Ltd.'s (NASDAQ:WVE) Intrinsic Value Is Potentially 52% Above Its Share Price (Simply Wall St.)
Dec-13-22 11:27AM	Wave, GSK enter strategic collaboration that could be worth up to $3.3 billion in milestone payments (MarketWatch) +32.69%
09:51AM	Wave Life Sciences Shares Move Higher On Therapeutic Pact With GSK Targeting Genetic Disorders (Benzinga)
07:30AM	Wave Life Sciences and GSK Announce Collaboration to Drive Discovery and Development of Oligonucleotide Therapeutics Focusing on Novel Genetic Targets (GlobeNewswire)
Nov-10-22 08:45AM	Wave Life Sciences (WVE) Reports Q3 Loss, Misses Revenue Estimates (Zacks) +5.84%
07:30AM	Wave Life Sciences Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Nov-09-22 08:30AM	Wave Life Sciences to Present at the Stifel 2022 Healthcare Conference (GlobeNewswire) -14.90%
Nov-03-22 08:30AM	Wave Life Sciences to Webcast Conference Call of Third Quarter 2022 Financial Results on November 10, 2022 (GlobeNewswire)
Oct-17-22 11:27AM	Wave Life Sciences (WVE) Soars 13.8%: Is Further Upside Left in the Stock? (Zacks) -11.73%
Oct-12-22 02:35PM	Atlas-backed gene-silencing startup winds down (American City Business Journals)
01:35PM	Is Wave Life Sciences (NASDAQ:WVE) In A Good Position To Deliver On Growth Plans? (Simply Wall St.)
Oct-03-22 08:30AM	Wave Life Sciences to Highlight Advancements from PRISM Platform at Upcoming Scientific Congresses (GlobeNewswire)
Sep-28-22 01:30PM	Wave Life Sciences Highlights Therapeutic Potential for WVE-006 for Alpha-1 Antitrypsin Deficiency and Progress Bringing RNA Editing to the Clinic During Analyst and Investor Event (GlobeNewswire)
Sep-27-22 08:30AM	Wave Life Sciences to Present at Chardans 6th Annual Genetic Medicines Conference (GlobeNewswire)
Sep-21-22 11:39AM	Wave Therapeutics (WVE) Up on Update From Huntington's Study (Zacks)
Sep-20-22 12:44PM	Wave Life Sciences Touts Positive Update From Its Lead Huntington's Program (Benzinga) +8.26%
07:30AM	Wave Life Sciences Announces Positive Update from Phase 1b/2a SELECT-HD Trial with Initial Results Indicating Allele-Selective Target Engagement with WVE-003 in Huntingtons Disease (GlobeNewswire)
Sep-16-22 08:30AM	Wave Life Sciences to Host Analyst and Investor Virtual Event, Towards the Clinic: Spotlight on RNA Editing for AATD, on September 28, 2022 (GlobeNewswire)
Aug-13-22 08:12AM	News Flash: 7 Analysts Think Wave Life Sciences Ltd. (NASDAQ:WVE) Earnings Are Under Threat (Simply Wall St.)
Aug-11-22 03:18PM	Why Wave Life Sciences Was Zooming Higher Today (Motley Fool) +16.86%
08:45AM	Wave Life Sciences (WVE) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
07:30AM	Wave Life Sciences Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Aug-03-22 06:15PM	Mirati (MRTX) Reports Q2 Loss, Tops Revenue Estimates (Zacks)

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Moran Kyle	Chief Financial Officer	Apr 03 '24	Sale	6.17	15,630	96,421	33,921	Apr 05 08:00 PM
RA CAPITAL MANAGEMENT, L.P.	Director	Dec 11 '23	Buy	5.00	1,000,000	5,000,000	19,202,009	Dec 13 04:33 PM
GSK plc	10% Owner	Dec 07 '23	Buy	5.00	3,300,000	16,500,000	13,983,761	Jan 30 04:39 PM
Moran Kyle	Chief Financial Officer	Aug 23 '23	Sale	4.75	37,062	176,119	46,120	Aug 23 09:15 PM

WVE

Wave Life Sciences Ltd.

Upgrade your FINVIZ experience